Article Details
Retrieved on: 2025-02-20 19:41:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
T-DXd consists of trastuzumab, a monoclonal antibody that targets HER2, and deruxtecan, a cytotoxic agent released into cancer cells causing DNA ...
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here